CINYSEHospital & Medical Service PlansFiscal year ends December 31
Cigna Group
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$298.50−3.80 (-1.26%)
Close on Oct 19, 2026
- Market cap
- $78.79B
- P/E (TTM)
- 13.5
- Dividend yield
- 2.02%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
89.9%
238M of 264M shares
Institutional holders
1,689
162 new, 101 sold out
Net institutional buying
3M
In Q2 2026
Insider trades, 12 months
1 buys · 19 sales
Net sold $65.84M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 19,941,446 | 7.40% | 13G (passive) amendment | Mar 31, 2025 |
| Vanguard Capital Management | 19,814,433 | 7.51% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CI | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 23,438,250 | 8.87% | $6.46B | +840,098 | 0.10% |
| Vanguard Capital Management LLC | 17,276,296 | 6.54% | $4.76B | +154,227 | 0.10% |
| State Street Corp | 12,682,259 | 4.80% | $3.50B | +399,118 | 0.10% |
| Dodge & Cox | 12,173,875 | 4.61% | $3.36B | +618,088 | 1.76% |
| Massachusetts Financial Services Co /Ma/ | 10,443,691 | 3.95% | $2.90B | −1,151,491 | 0.92% |
| Sanders Capital, LLC | 10,144,617 | 3.84% | $2.80B | −145,765 | 2.80% |
| FMR LLC | 8,018,189 | 3.03% | $2.21B | −2,939,083 | 0.10% |
| Geode Capital Management, LLC | 6,268,347 | 2.37% | $1.72B | +68,005 | 0.09% |
| Vanguard Portfolio Management LLC | 6,228,614 | 2.36% | $1.72B | +65,176 | 0.08% |
| GQG Partners LLC | 5,908,707 | 2.24% | $1.63B | −93,741 | 3.03% |
| JPMorgan Chase & Co | 5,194,363 | 1.97% | $1.45B | −611,276 | 0.08% |
| Morgan Stanley | 3,690,812 | 1.40% | $1.02B | +258,009 | 0.05% |
| Norges Bank | 3,562,699 | 1.35% | $982.16M | New | 0.10% |
| Bank Of America Corp /De/ | 3,002,366 | 1.14% | $827.69M | −179,717 | 0.05% |
| Arrowstreet Capital, Limited Partnership | 2,849,302 | 1.08% | $785.50M | −10,987 | 0.35% |
| Northern Trust Corp | 2,730,687 | 1.03% | $752.80M | +28,086 | 0.09% |
| Ameriprise Financial Inc | 2,608,447 | 0.99% | $719.18M | −174,792 | 0.15% |
| Grantham, Mayo, Van Otterloo & Co. LLC | 2,577,075 | 0.98% | $710.45M | −21,143 | 1.60% |
| Dimensional Fund Advisors LP | 2,512,025 | 0.95% | $692.58M | +85,807 | 0.13% |
| Invesco Ltd. | 2,403,612 | 0.91% | $662.63M | −89,762 | 0.05% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1,689 | 238M | 89.9% | 162 / 674 | 575 / 101 | 19M | 17M |
| Q1 2026 | 1,658 | 235M | 89.0% | 155 / 671 | 557 / 119 | 44M | 18M |
| Q4 2025 | 1,650 | 237M | 89.5% | 200 / 561 | 636 / 132 | 24M | 27M |
| Q3 2025 | 1,611 | 240M | 90.9% | 116 / 577 | 640 / 210 | 21M | 18M |
| Q2 2025 | 1,729 | 237M | 89.6% | 169 / 651 | 592 / 105 | 16M | 20M |
| Q1 2025 | 1,685 | 240M | 91.0% | 195 / 580 | 626 / 131 | 13M | 13M |
| Q4 2024 | 1,639 | 244M | 92.3% | 190 / 534 | 658 / 213 | 17M | 18M |
| Q3 2024 | 1,697 | 246M | 93.2% | 143 / 621 | 604 / 87 | 34M | 11M |
| Q2 2024 | 1,657 | 248M | 93.7% | 143 / 617 | 561 / 120 | 12M | 31M |
| Q1 2024 | 1,655 | 268M | 100.0% | 185 / 546 | 620 / 124 | 20M | 16M |
| Q4 2023 | 1,619 | 267M | 100.0% | 238 / 512 | 598 / 86 | 27M | 16M |
| Q3 2023 | 1,486 | 256M | 96.8% | 120 / 504 | 567 / 95 | 13M | 15M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of CI | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 8,398,680 | 3.18% | $2.32B | 0.10% | Jun 30, 2026 |
| Dodge & Cox Stock Fund | 7,985,072 | 3.02% | $2.20B | 1.86% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 6,854,355 | 2.59% | $1.89B | 0.11% | Jun 30, 2026 |
| MFS Value Fund | 5,165,954 | 1.96% | $1.43B | 2.80% | May 31, 2026 |
| iShares Core S&P 500 ETF | 3,637,728 | 1.38% | $1.00B | 0.11% | Jun 30, 2026 |
| Fidelity 500 Index Fund | 3,371,552 | 1.28% | $935.27M | 0.11% | May 31, 2026 |
| Vanguard Windsor Ii Fund | 2,866,486 | 1.08% | $799.89M | 1.20% | Jul 31, 2026 |
| Vanguard Value Index Fund | 2,518,810 | 0.95% | $694.39M | 0.27% | Jun 30, 2026 |
| State Street(R) Health Care Select Sector SPDR(R) ETF | 1,868,792 | 0.71% | $515.19M | 1.27% | Jun 30, 2026 |
| Vanguard Institutional Index Fund | 1,436,072 | 0.54% | $395.90M | 0.11% | Jun 30, 2026 |
| Strategic Advisers Fidelity U.S. Total Stock Fund | 1,104,902 | 0.42% | $306.50M | 0.12% | May 31, 2026 |
| Vanguard High Dividend Yield Index Fund | 1,051,091 | 0.40% | $293.31M | 0.30% | Jul 31, 2026 |
| JPMorgan Equity Income Fund | 976,908 | 0.37% | $269.31M | 0.62% | Jun 30, 2026 |
| American Balanced Fund | 870,000 | 0.33% | $239.84M | 0.08% | Jun 30, 2026 |
| Vanguard Health Care Index Fund | 802,292 | 0.30% | $222.56M | 1.17% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| David Cordani | Chairman & CEO, Director | 658,302 | 0.25% | May 14, 2026 |
| Everett Neville | See Remarks | 5,053 | 0.00% | Sep 8, 2026 |
| Brian C. Evanko | See Remarks | 67,564 | 0.03% | Sep 3, 2026 |
| Bryan Holgerson | See Remarks | 7,693 | 0.00% | Aug 20, 2026 |
| Nicole S. Jones | See Remarks | 27,331 | 0.01% | Aug 20, 2026 |
| Adam Kautzner | See Remarks | 13,533 | 0.01% | Jul 9, 2026 |
| Matthew Perlberg | See Remarks | 9,345 | 0.00% | Jul 9, 2026 |
| Jason D. Sadler | See Remarks | 34,705 | 0.01% | Jul 9, 2026 |
| Paul A. Sanford | See Remarks | 4,335 | 0.00% | Jul 9, 2026 |
| Jamie G. Kates | Chief Accounting Officer | 2,368 | 0.00% | Jun 16, 2026 |
| Durga Prasad Koka | EVP, Global CIO | 6,552 | 0.00% | Jun 3, 2026 |
| Andrea L. Nelson | EVP, General Counsl & Corp Sec | 3,912 | 0.00% | Apr 3, 2026 |
| Ann M. Dennison | EVP, CFO | 8,154 | 0.00% | Mar 3, 2026 |
| David J. Brailer | EVP & Chief Health Officer | 17,525 | 0.01% | Sep 3, 2025 |
| Noelle K. Eder | See Remarks | 13,590 | 0.01% | Mar 11, 2025 |
| Eric P. Palmer | See Remarks | 75,295 | 0.03% | Mar 4, 2025 |
| George Kurian | Director | 4,560 | 0.00% | Sep 2, 2026 |
| Eric C. Wiseman | Director | 23,940 | 0.01% | Apr 24, 2026 |
| Eric J. Foss | Director | 36,696 | 0.01% | Apr 24, 2026 |
| Donna F. Zarcone | Director | 27,517 | 0.01% | Apr 24, 2026 |
| Neesha Hathi | Director | 4,151 | 0.00% | Apr 24, 2026 |
| Michael J. Hennigan | Director | 1,350 | 0.00% | Apr 24, 2026 |
| Mark B. McClellan | Director | 6,891 | 0.00% | Apr 24, 2026 |
| Kimberly A. Ross | Director | 5,294 | 0.00% | Apr 24, 2026 |
| Kathleen M. Mazzarella | Director | 6,891 | 0.00% | Apr 24, 2026 |
| Philip Ozuah | Director | 2,583 | 0.00% | Apr 24, 2026 |
| Elder Granger | Director | 6,109 | 0.00% | Apr 25, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Everett Neville See Remarks | Sep 3, 2026 | Sale(10b5-1 plan) | −617 | $284.05 | $175.26K | 5,053 |
| Brian C. Evanko See Remarks | Sep 1, 2026 | Award | +3,113 | – | – | 41,030 |
| Nicole S. Jones See Remarks | Aug 18, 2026 | Sale(10b5-1 plan) | −2,677 | $279.61 | $748.52K | 25,880 |
| Nicole S. Jones See Remarks | Aug 5, 2026 | Option exercise | +1,301 | $192.02 | $249.82K | 28,557 |
| Nicole S. Jones See Remarks | Aug 4, 2026 | Option exercise | +14,045 | $192.02 | $2.70M | 46,692 |
| Nicole S. Jones See Remarks | Aug 4, 2026 | Sale(10b5-1 plan) | −19,436 | $276.27 | $5.37M | 27,256 |
| Jamie G. Kates Chief Accounting Officer | Jun 12, 2026 | Sale | −899 | $298.61 | $268.45K | 2,368 |
| Jamie G. Kates Chief Accounting Officer | Jun 12, 2026 | Option exercise | +899 | $152.89 | $137.45K | 3,267 |
| Durga Prasad Koka EVP, Global CIO | Jun 1, 2026 | Tax withholding | −729 | $275.53 | $200.86K | 6,552 |
| David Cordani Chairman & CEO, Director | May 13, 2026 | Option exercise | +7,971 | $197.35 | $1.57M | 57,766 |
| David Cordani Chairman & CEO, Director | May 13, 2026 | Option exercise | +15,458 | $149.14 | $2.31M | 49,795 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Sale(10b5-1 plan) | −2,231 | $298.53 | $666.02K | 34,337 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Sale(10b5-1 plan) | −15,319 | $298.24 | $4.57M | 36,568 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Sale(10b5-1 plan) | −2,017 | $296.84 | $598.73K | 51,887 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Sale(10b5-1 plan) | −34,641 | $295.98 | $10.25M | 53,904 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Sale(10b5-1 plan) | −38,487 | $294.98 | $11.35M | 88,545 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Sale(10b5-1 plan) | −2,142 | $293.92 | $629.58K | 127,032 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Sale(10b5-1 plan) | −7,861 | $292.88 | $2.30M | 129,174 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Sale(10b5-1 plan) | −12,315 | $291.95 | $3.60M | 137,035 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Sale(10b5-1 plan) | −13,732 | $291.01 | $4.00M | 149,350 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Sale(10b5-1 plan) | −41,099 | $290.00 | $11.92M | 163,082 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Sale(10b5-1 plan) | −13,839 | $288.85 | $4.00M | 204,181 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Sale(10b5-1 plan) | −14,292 | $287.96 | $4.12M | 218,020 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Sale(10b5-1 plan) | −3,903 | $286.83 | $1.12M | 232,312 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Option exercise | +85,519 | $197.35 | $16.88M | 236,215 |
| David Cordani Chairman & CEO, Director | May 12, 2026 | Option exercise | +103,595 | $149.14 | $15.45M | 150,696 |
| Michael J. Hennigan Director | Apr 22, 2026 | Award | +782 | – | – | 1,350 |
| Neesha Hathi Director | Apr 22, 2026 | Award | +782 | – | – | 4,151 |
| Eric J. Foss Director | Apr 22, 2026 | Award | +782 | – | – | 36,696 |
| Mark B. McClellan Director | Apr 22, 2026 | Award | +782 | – | – | 6,891 |
| George Kurian Director | Apr 22, 2026 | Award | +782 | – | – | 4,560 |
| Philip Ozuah Director | Apr 22, 2026 | Award | +782 | – | – | 2,583 |
| Kathleen M. Mazzarella Director | Apr 22, 2026 | Award | +782 | – | – | 6,891 |
| Kimberly A. Ross Director | Apr 22, 2026 | Award | +782 | – | – | 5,294 |
| Donna F. Zarcone Director | Apr 22, 2026 | Award | +782 | – | – | 27,517 |
| Eric C. Wiseman Director | Apr 22, 2026 | Award | +782 | – | – | 23,940 |
| Everett Neville See Remarks | Mar 2, 2026 | Sale(10b5-1 plan) | −1,719 | $288.91 | $496.64K | 5,670 |
| Nicole S. Jones See Remarks | Mar 2, 2026 | Sale(10b5-1 plan) | −2,307 | $288.91 | $666.52K | 32,647 |
| Brian C. Evanko See Remarks | Feb 27, 2026 | Tax withholding | −2,979 | $287.55 | $856.61K | 39,705 |
| Brian C. Evanko See Remarks | Feb 27, 2026 | Tax withholding | −1,788 | $287.55 | $514.14K | 37,917 |
| Brian C. Evanko See Remarks | Feb 27, 2026 | Award | +6,428 | – | – | 32,897 |
| Brian C. Evanko See Remarks | Feb 27, 2026 | Award | +9,787 | – | – | 42,684 |
| Jamie G. Kates Chief Accounting Officer | Feb 27, 2026 | Tax withholding | −61 | $287.55 | $17.54K | 2,368 |
| Jamie G. Kates Chief Accounting Officer | Feb 27, 2026 | Award | +205 | – | – | 1,891 |
| Jamie G. Kates Chief Accounting Officer | Feb 27, 2026 | Award | +609 | – | – | 2,500 |
| Jamie G. Kates Chief Accounting Officer | Feb 27, 2026 | Tax withholding | −71 | $287.55 | $20.42K | 2,429 |
| Ann M. Dennison EVP, CFO | Feb 27, 2026 | Award | +5,234 | – | – | 8,154 |
| Ann M. Dennison EVP, CFO | Feb 27, 2026 | Tax withholding | −409 | $287.55 | $117.61K | 7,745 |
| Durga Prasad Koka EVP, Global CIO | Feb 27, 2026 | Tax withholding | −122 | $287.55 | $35.08K | 7,379 |
| Durga Prasad Koka EVP, Global CIO | Feb 27, 2026 | Award | +2,678 | – | – | 7,501 |
| Durga Prasad Koka EVP, Global CIO | Feb 27, 2026 | Tax withholding | −98 | $287.55 | $28.18K | 7,281 |
| Durga Prasad Koka EVP, Global CIO | Feb 27, 2026 | Award | +499 | – | – | 4,823 |
| David Cordani Chairman & CEO, Director | Feb 27, 2026 | Award | +17,389 | – | – | 62,533 |
| David Cordani Chairman & CEO, Director | Feb 27, 2026 | Award | +23,788 | – | – | 45,144 |
| David Cordani Chairman & CEO, Director | Feb 27, 2026 | Tax withholding | −11,024 | $287.55 | $3.17M | 51,509 |
| David Cordani Chairman & CEO, Director | Feb 27, 2026 | Tax withholding | −4,408 | $287.55 | $1.27M | 47,101 |
| Everett Neville See Remarks | Feb 27, 2026 | Tax withholding | −517 | $287.55 | $148.66K | 7,389 |
| Everett Neville See Remarks | Feb 27, 2026 | Award | +2,602 | – | – | 6,111 |
| Everett Neville See Remarks | Feb 27, 2026 | Award | +2,678 | – | – | 8,789 |
| Everett Neville See Remarks | Feb 27, 2026 | Tax withholding | −883 | $287.55 | $253.91K | 7,906 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Everett Neville Officer | Sep 3, 2026 | 617 | $175.26K | Sep 3, 2026 | Restricted Stock Vesting |
| Nicole S. Jones Officer | Aug 18, 2026 | 2,677 | $748.42K | Aug 18, 2026 | Stock Option Exercise |
| Nicole S. Jones Officer | Aug 4, 2026 | 19,436 | $5.37M | Aug 4, 2026 | Restricted Stock Vesting |
| Jamie G. Kates Officer | Jun 12, 2026 | 899 | $268.45K | Jun 12, 2026 | Stock Option Exercise |
| David Cordani Officer, Director | May 12, 2026 | 201,878 | $59.11M | May 12, 2026 | Restricted Stock Vesting |
| Nicole S. Jones Officer | Mar 2, 2026 | 2,307 | $666.52K | Mar 2, 2026 | Restricted Stock Vesting |
| Everett Neville Officer | Mar 2, 2026 | 1,719 | $496.64K | Mar 2, 2026 | Restricted Stock Vesting |
| Elder Granger Former Director | Feb 6, 2026 | 6,109 | $1.79M | Feb 6, 2026 | Restricted Stock Vesting |
| Brian C. Evanko Officer | Oct 3, 2025 | 5,368 | $1.61M | Oct 3, 2025 | Option Granted 03/01/2016 |
| Nicole S. Jones Officer | Aug 15, 2025 | 28,526 | $8.56M | Aug 15, 2025 | Restricted Stock Vesting |
| Noelle K. Eder Former Officer | Aug 12, 2025 | 35,711 | $9.82M | Aug 12, 2025 | Options Granted - 02/24/2021 |
| Eric P. Palmer Former Officer | May 9, 2025 | 610 | $204.40K | May 9, 2025 | Option Granted - 02/24/2021 |
| Eric P. Palmer Former Officer | May 8, 2025 | 14,985 | $5.03M | May 8, 2025 | Option Granted - 02/24/2021 |
| Eric P. Palmer Former Officer | May 7, 2025 | 87,171 | $29.20M | May 7, 2025 | Option Granted - 02/27/2019 |
| Eric P. Palmer Former Officer | May 6, 2025 | 35,977 | $12.04M | May 6, 2025 | Option Granted 02/28/2018 |